Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer

Stephanie M Barrows1 Market Access and Outcomes Strategy, RTI Health Solutions, Ann Arbor, MI, USA, [email protected]Correspondence[email protected]

Kelly Wright1 Market Access and Outcomes Strategy, RTI Health Solutions, Ann Arbor, MI, USA, [email protected]

Catherine Copley-Merriman1 Market Access and Outcomes Strategy, RTI Health Solutions, Ann Arbor, MI, USA, [email protected]

James A Kaye2 Epidemiology and Clinical Research, RTI Health Solutions, Waltham, MA, USA

Marc Chioda3 Medical Affairs, Pfizer, Inc., New York, NY, USA

Robin Wiltshire4 Medical Affairs, Pfizer Limited, Walton Oaks, UK

Knut Martin Torgersen5 Medical Affairs, Pfizer, Inc., Oslo, Norway

Elizabeth T Masters6 Health Economics and Outcomes Research, Pfizer, Inc., New York, NY, USA

show all

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Valerio Nardone, Caterina Romeo, Emma D’Ippolito, Pierpaolo Pastina, Maria D’Apolito, Luigi Pirtoli, Michele Caraglia, Luciano Mutti, Giovanna Bianco, Antonella Consuelo Falzea, Rocco Giannicola, Antonio Giordano, Pierosandro Tagliaferri, Claudia Vinciguerra, Isacco Desideri, Mauro Loi, Alfonso Reginelli, Salvatore Cappabianca, Pierfrancesco Tassone & Pierpaolo Correale. (2023) The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review. La radiologia medica 128:3, pages 316-329.
Crossref

Joelle C. Boulos, Mohamed E. M. Saeed, Manik Chatterjee, Yagmur Bülbül, Francesco Crudo, Doris Marko, Markus Munder, Sabine M. Klauck & Thomas Efferth. (2021) Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells. Pharmaceuticals 14:11, pages 1126.
Crossref

Agnieszka Rybarczyk-Kasiuchnicz, Rodryg Ramlau & Katarzyna Stencel. (2021) Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma. International Journal of Molecular Sciences 22:2, pages 593.
Crossref

Michael Chahin, Nithya Krishnan, Trevanne Matthews-Hew, Jason Hew & Dat Pham. (2020) Metastatic Anaplastic Lymphoma Kinase Rearrangement-Positive Adenocarcinoma of Occult Primary Mimicking Ovarian Cancer. Cureus.
Crossref

Ravi Salgia, Isa Mambetsariev, Tingting Tan, Amanda Schwer, Daryl P. Pearlstein, Hazem Chehabi, Angel Baroz, Jeremy Fricke, Rebecca Pharaon, Hannah Romo, Thomas Waddington, Razmig Babikian, Linda Buck, Prakash Kulkarni, Mary Cianfrocca, Benjamin Djulbegovic & Sumanta K. Pal. (2020) Complex Oncological Decision-Making Utilizing Fast-and-Frugal Trees in a Community Setting—Role of Academic and Hybrid Modeling. Journal of Clinical Medicine 9:6, pages 1884.
Crossref

Swapnil Rajurkar, Isa Mambetsariev, Rebecca Pharaon, Benjamin Leach, TingTing Tan, Prakash Kulkarni & Ravi Salgia. (2020) Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy Strategies. Journal of Clinical Medicine 9:6, pages 1870.
Crossref

Zhenya Tang, Lu Wang, Guilin Tang & L. Jeffrey Medeiros. (2019) Fluorescence in Situ Hybridization (FISH) for Detecting Anaplastic Lymphoma Kinase (ALK) Rearrangement in Lung Cancer: Clinically Relevant Technical Aspects. International Journal of Molecular Sciences 20:16, pages 3939.
Crossref

Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date